$SAVA
CASSAVA SCIENCES INC

2018 Q4 Form 10-Q Financial Statement

#000106953018000060 Filed on October 30, 2018

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q3 2017 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $750.0K $850.0K $980.0K
YoY Change -14.77% -13.27% 11.36%
% of Gross Profit
Research & Development $0.00 $1.463M $1.619M
YoY Change -100.0% -9.64% -39.14%
% of Gross Profit
Depreciation & Amortization $0.00 $100.0K $100.0K
YoY Change 0.0%
% of Gross Profit
Operating Expenses $750.0K $1.284M $2.596M
YoY Change -69.01% -50.54% -26.67%
Operating Profit -$1.284M -$2.596M
YoY Change -50.54%
Interest Expense $70.00K $20.00K $10.00K
YoY Change 600.0% 100.0% -50.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$680.0K -$1.270M -$2.590M
YoY Change -71.9% -50.97% -26.42%
Income Tax
% Of Pretax Income
Net Earnings -$680.0K -$1.267M -$2.590M
YoY Change -71.9% -51.08% -26.42%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$39.47K -$106.2K -$396.0K
COMMON SHARES
Basic Shares Outstanding 17.22M
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q4 2018 Q3 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.80M $20.40M $11.90M
YoY Change 88.57% 71.43% -45.41%
Cash & Equivalents $19.81M $20.44M $11.92M
Short-Term Investments $0.00
Other Short-Term Assets $233.0K $276.0K $300.0K
YoY Change 26.63% -8.0% -40.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $20.04M $20.72M $12.20M
YoY Change 87.94% 69.84% -45.05%
LONG-TERM ASSETS
Property, Plant & Equipment $87.00K $104.0K $200.0K
YoY Change -44.23% -48.0% -33.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $12.00K $12.00K
YoY Change 0.0%
Total Long-Term Assets $99.00K $116.0K $200.0K
YoY Change -41.07% -42.0% -33.33%
TOTAL ASSETS
Total Short-Term Assets $20.04M $20.72M $12.20M
Total Long-Term Assets $99.00K $116.0K $200.0K
Total Assets $20.14M $20.84M $12.40M
YoY Change 85.94% 68.03% -44.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $294.0K $549.0K $700.0K
YoY Change -30.66% -21.57% -36.36%
Accrued Expenses $156.0K $300.0K $300.0K
YoY Change -60.9% 0.0% -72.73%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $511.0K $862.0K $1.000M
YoY Change -54.86% -13.8% -54.55%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $511.0K $862.0K $1.000M
Total Long-Term Liabilities $0.00
Total Liabilities $511.0K $862.0K $1.000M
YoY Change -54.86% -13.8% -54.55%
SHAREHOLDERS EQUITY
Retained Earnings -$164.0M -$163.3M
YoY Change 4.17%
Common Stock $17.00K $17.00K
YoY Change 142.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $19.63M $19.97M $11.40M
YoY Change
Total Liabilities & Shareholders Equity $20.14M $20.84M $12.40M
YoY Change 85.94% 68.03% -44.89%

Cashflow Statement

Concept 2018 Q4 2018 Q3 2017 Q3
OPERATING ACTIVITIES
Net Income -$680.0K -$1.267M -$2.590M
YoY Change -71.9% -51.08% -26.42%
Depreciation, Depletion And Amortization $0.00 $100.0K $100.0K
YoY Change 0.0%
Cash From Operating Activities -$600.0K -$1.400M -$2.200M
YoY Change -57.14% -36.36% -21.43%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -100.0K 12.30M 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -600.0K -1.400M -2.200M
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities -100.0K 12.30M 0.000
Net Change In Cash -700.0K 10.90M -2.200M
YoY Change -50.0% -595.45% -35.29%
FREE CASH FLOW
Cash From Operating Activities -$600.0K -$1.400M -$2.200M
Capital Expenditures $0.00
Free Cash Flow -$2.200M
YoY Change -18.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Period End Date
DocumentPeriodEndDate
2018-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001069530
CY2018Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17219300
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
PAIN THERAPEUTICS INC
dei Trading Symbol
TradingSymbol
PTIE
CY2017Q4 ptie Cash And Cash Equivalents Short Term Investment Fair Value
CashAndCashEquivalentsShortTermInvestmentFairValue
10479000
CY2018Q3 ptie Cash And Cash Equivalents Short Term Investment Fair Value
CashAndCashEquivalentsShortTermInvestmentFairValue
20444000
CY2017Q4 ptie Cash And Cash Equivalents Short Term Investment Unrealized Gains Net Of Tax
CashAndCashEquivalentsShortTermInvestmentUnrealizedGainsNetOfTax
CY2018Q3 ptie Cash And Cash Equivalents Short Term Investment Unrealized Gains Net Of Tax
CashAndCashEquivalentsShortTermInvestmentUnrealizedGainsNetOfTax
CY2018Q3 us-gaap Assets Current
AssetsCurrent
20720000
CY2017Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
10479000
CY2018Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
20444000
CY2017Q4 ptie Cash And Cash Equivalents Short Term Investment Unrealized Loss Net Of Tax
CashAndCashEquivalentsShortTermInvestmentUnrealizedLossNetOfTax
CY2018Q3 ptie Cash And Cash Equivalents Short Term Investment Unrealized Loss Net Of Tax
CashAndCashEquivalentsShortTermInvestmentUnrealizedLossNetOfTax
ptie Investments Maturity Period
InvestmentsMaturityPeriod
P1Y
ptie Issuance Of Common Stock Net Of Issuance Costs
IssuanceOfCommonStockNetOfIssuanceCosts
14170000
ptie Number Of Grants Awarded
NumberOfGrantsAwarded
2
ptie Reduction To Reasearch And Development Expense
ReductionToReasearchAndDevelopmentExpense
900000
CY2017Q3 ptie Reduction To Reasearch And Development Expense
ReductionToReasearchAndDevelopmentExpense
800000
ptie Reduction To Reasearch And Development Expense
ReductionToReasearchAndDevelopmentExpense
1900000
CY2018Q3 ptie Reduction To Reasearch And Development Expense
ReductionToReasearchAndDevelopmentExpense
1100000
ptie Stock Option And Performance Award Activity
StockOptionAndPerformanceAwardActivity
<div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:63.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:16.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:16.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:63.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.50pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.50pt;font-size: 10pt"> <font style="display: inline;font-family:Arial;font-weight:bold;color:#000000;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.50pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:16.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.50pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.50pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:16.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.50pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:1.50pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:63.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:16.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;color:#000000;font-size:8pt;">Stock Options</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:16.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt"> <font style="display: inline;font-weight:bold;color:#000000;font-size:8pt;">Performance Awards</font></p> </td> </tr> <tr> <td valign="bottom" style="width:63.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:12.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;color:#000000;font-size:9pt;">&#xFEFF;</font><font style="display: inline;color:#000000;font-size:9pt;">Outstanding as of December 31, 2017</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:12.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:16.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:12.00pt;color:#000000;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">2,982,155&nbsp; </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:12.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:16.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:12.00pt;color:#000000;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">152,340&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:63.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Options granted</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:12.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:16.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:12.00pt;color:#000000;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">247,500&nbsp; </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:12.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:16.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;color:#000000;font-size:9pt;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:63.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Options exercised</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:12.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:16.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;color:#000000;font-size:9pt;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:12.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:16.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:12.00pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;color:#000000;font-size:9pt;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="bottom" style="width:63.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:12.00pt;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Options forfeited/canceled</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:12.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:16.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:12.00pt;color:#000000;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">(309,291) </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:12.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:16.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:12.00pt;color:#000000;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">(14,285) </td> </tr> <tr> <td valign="bottom" style="width:63.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:12.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;color:#000000;font-size:9pt;">&#xFEFF;</font><font style="display: inline;color:#000000;font-size:9pt;">Outstanding as of September 30, 2018</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:12.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:16.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:12.00pt;color:#000000;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">2,920,364&nbsp; </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:12.00pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:16.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:12.00pt;color:#000000;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">138,055&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:63.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:5.25pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:5.25pt;font-size: 10pt"> <font style="display: inline;font-family:Arial;color:#000000;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:5.25pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:16.02%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:5.25pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:5.25pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:16.24%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:5.25pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;height:5.25pt;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div>
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
424000
CY2018Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
549000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
399000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
167091000
CY2018Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
183236000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2223000
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
688000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1985000
CY2017Q4 us-gaap Assets
Assets
10831000
CY2018Q3 us-gaap Assets
Assets
20836000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
10663000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16615000
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11916000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10479000
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20444000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4699000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
9965000
CY2017Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
10479000
CY2018Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
20444000
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6595509
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17219300
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6595509
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17219300
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
7000
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
17000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
51000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
52000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.45
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.40
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.69
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
309000
CY2018Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
305000
CY2018Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2018Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20836000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1132000
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
862000
CY2017Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
CY2018Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
977000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3455000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2945000
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
848000
CY2018Q3 us-gaap Grants Receivable
GrantsReceivable
6700000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
417000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
125000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-27000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-399000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-37000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-4000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-68000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
92000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
8000
us-gaap Interest And Other Income
InterestAndOtherIncome
33000
CY2017Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
6000
us-gaap Interest And Other Income
InterestAndOtherIncome
32000
CY2018Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
17000
CY2017Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
CY2018Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
CY2017Q4 us-gaap Liabilities
Liabilities
1132000
CY2018Q3 us-gaap Liabilities
Liabilities
862000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10831000
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-2590000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14170000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2101000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6800000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4205000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-1267000
us-gaap Operating Expenses
OperatingExpenses
9526000
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
2596000
us-gaap Operating Expenses
OperatingExpenses
5912000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
1284000
us-gaap Operating Income Loss
OperatingIncomeLoss
-9526000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2596000
us-gaap Operating Income Loss
OperatingIncomeLoss
-5912000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1284000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
285000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
91000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
99000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
95000
CY2018Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8000
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
184000
CY2018Q3 us-gaap Other Assets Current
OtherAssetsCurrent
276000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12000
CY2018Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12000
us-gaap Other Noncash Income
OtherNoncashIncome
2000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
399000
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1619000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2967000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
436000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-157399000
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-163279000
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14170000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
2100000
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
400000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
156000
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
104000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6071000
us-gaap Share Based Compensation
ShareBasedCompensation
2223000
us-gaap Share Based Compensation
ShareBasedCompensation
1985000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2018Q3 us-gaap Shares Issued
SharesIssued
10623791
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
9699000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
19974000
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9699000
CY2018Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
19974000
us-gaap Use Of Estimates
UseOfEstimates
<div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Use of Estimates</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-style:italic;">&#xFEFF;</font> </p> <p style="margin:0pt;text-indent:18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">We make estimates and assumptions in preparing our financial statements in conformity with U.S. GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenue earned and expenses incurred during the reporting period. We evaluate our estimates on an ongoing basis, including those estimates related to agreements, research collaborations and investments. Actual results could differ from these estimates</font><font style="display: inline;color:#000000;"> and assumptions.</font> </p> <p><font size="1"> </font></p> </div> </div>
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6537000
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6538000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8498000
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11959000

Files In Submission

Name View Source Status
0001069530-18-000060-index-headers.html Edgar Link pending
0001069530-18-000060-index.html Edgar Link pending
0001069530-18-000060.txt Edgar Link pending
0001069530-18-000060-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ptie-20180930.xml Edgar Link completed
ptie-20180930.xsd Edgar Link pending
ptie-20180930x10q.htm Edgar Link pending
ptie-20180930xex31_1.htm Edgar Link pending
ptie-20180930xex32_1.htm Edgar Link pending
ptie-20180930_cal.xml Edgar Link unprocessable
ptie-20180930_def.xml Edgar Link unprocessable
ptie-20180930_lab.xml Edgar Link unprocessable
ptie-20180930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending